Riskpilot← Back to searchSign inGet full accessAPOWEBSHOP A/S
A/SActiveCVR 33870736Fruebjergvej 3Retail sale of pharmaceutical products · NACE 4773Est. 2011— employees
Revenue 2025
DKK 85K
+390% vs 2024
EBITDA margin
60.5%
+2108% vs 2024
Equity ratio
30.3%
Financial strength
Net profit 2025
DKK 42K
-28% vs 2024
| Revenue | DKK 85K | +390% |
| EBITDA | DKK 52K | +2108% |
| Net profit | DKK 42K | -28% |
| Total assets | DKK 5M | +39% |
| Equity | DKK 1,5M | +3% |
| Employees | — | — |
Legal name
APOWEBSHOP A/S
CVR number
33870736
Legal form
Aktieselskab
NACE code
4773 · Retail sale of pharmaceutical products
Founded
17. august 2011
Share capital
DKK 968.000
Employees
—
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af bestyrelsesformanden i forening med den administrerende direktør, af næstformanden i forening med den administrerende direktør, eller af to bestyrelsesmedlemmer i forening.
Company purpose
Selskabets formål er at udvikle, markedsføre og drive en webportal hvorfra andre virksomheder kan sælge lægemidler, kosttilskud, medicinsk udstyr og beslægtede varer, herunder visse kosmetiske produkter. Derudover har selskabet et engrossalg af kosttilskud, medicinsk udstyr, kosmetik og beslægtede varer.
Address
Fruebjergvej 3
Email
apotekeren@apotekerenamba.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | -83 | 185 | 780 | 17 | 85 |
| Staff expenses | -20 | -20 | -20 | -20 | -34 |
| EBITDA | -103 | 165 | 760 | -3 | 52 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | -103 | 165 | 760 | -3 | 52 |
| Net financials | -53 | -41 | -12 | 62 | -9 |
| Profit before tax | -156 | 124 | 748 | 59 | 42 |
| Tax | -0 | -0 | -0 | -0 | -0 |
| Net profit | -156 | 124 | 748 | 59 | 42 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3.411 | 3.705 | 5.026 | 3.577 | 4.985 |
| Equity | 535 | 659 | 1.407 | 1.466 | 1.508 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2.876 | 3.046 | 3.619 | 2.111 | 3.477 |
| Total debt | 2.876 | 3.046 | 3.619 | 2.111 | 3.477 |
EBITDA margin
60.5%
This company
15.8%
Market median
+283% vs market
20212025
Equity ratio
30.3%
This company
38.2%
Market median
+21% vs market
20212025
Return on equity
2.8%
This company
18.4%
Market median
-85% vs market
20212025
Net profit margin
49.6%
This company
8.1%
Market median
+512% vs market
20212025
Asset turnover
0.02×
This company
1.12×
Market median
-98% vs market
20212025
Debt / equity
2.31×
This company
0.62×
Market median
-273% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
DB Chief Executive Officer | Chief Executive Officer | 2011 |
| Name | Role | Member since |
|---|---|---|
| Current (6) | ||
| Deputy Chairman | 2025 | |
| Board of Directors | 2025 | |
| Board of Directors | 2023 | |
| Chairman | 2023 | |
| Board of Directors | 2024 | |
| Board of Directors | 2022 | |
| Former (13) | ||
| Board of Directors | 2014 – 2015 | |
| Board of Directors | 2014 – 2015 | |
| Board of Directors | 2013 – 2022 | |
| Board of Directors | 2011 – 2013 | |
| Deputy Chairman | 2014 – 2015 | |
| Board of Directors | 2016 – 2020 | |
| Board of Directors | 2011 – 2014 | |
| Board of Directors | 2011 – 2016 | |
| Deputy Chairman | 2020 – 2022 | |
| Deputy Chairman | 2017 – 2020 | |
| Board of Directors | 2011 – 2014 | |
| Board of Directors | 2020 – 2022 | |
| Deputy Chairman | 2023 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 33.33–49.99% | 33.33–49.99% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
APOTEKEREN A.M.B.A.
APOWEBSHOP A/S Board members of APOWEBSHOP A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Dorte Brix Nagell | Chief Executive Officer | 0 companies |
| Lene Bjerring Damgaard | Board of Directors | 0 companies |
| Steffen Bo Asbjørn de Teilman Hald | Board of Directors | 0 companies |
| Jakob Møller | Deputy Chairman | 0 companies |
| Peer Nørkjær | Board of Directors | 0 companies |
| Thea Kæstel | Board of Directors | 0 companies |
| Sten Grønved Nielsen | Board of Directors | 0 companies |
| Camilla Bangert | Deputy Chairman | 0 companies |
| Christina Weidemann Pedersen | Board of Directors | 0 companies |
| Peder Gunnersen Harboe | Board of Directors | 0 companies |
| Bente Wittrup Præstbrogaard | Board of Directors | 0 companies |
| Niels-Philip Bachmann Søgaard | Board of Directors | 0 companies |
| Niels Kristensen | Deputy Chairman | 0 companies |
| Jette Kristensen | Deputy Chairman | 0 companies |
| Inga Vilstrup | Board of Directors | 0 companies |
| Michael Bobak | Board of Directors | 0 companies |
| Per Wijngaard | Deputy Chairman | 0 companies |
| Trine Frost Hansen | Chairman | 0 companies |
| Peter Oksbjerg Krüger Bak | Board of Directors | 0 companies |
| Kristian Østergaard Nielsen | Board of Directors | 0 companies |